Mariam Jamal-Hanjani’s talk highlights need for biomarkers to identify patients at risk of developing cachexia - LUNGevity Foundation

Mariam Jamal-Hanjani’s talk highlights need for biomarkers to identify patients at risk of developing cachexia – LUNGevity Foundation

LUNGevity Foundation shared a post on X:

“Mariam Jamal-Hanjani’s talk highlights need for biomarkers to identify patients at risk of developing cachexia. Data from TRACERx study shows site of metastasis predicts cachexia in patients with lung cancer.”

Mariam Jamal-Hanjani’s talk highlights need for biomarkers to identify patients at risk of developing cachexia - LUNGevity Foundation Mariam Jamal-Hanjani’s talk highlights need for biomarkers to identify patients at risk of developing cachexia - LUNGevity Foundation Mariam Jamal-Hanjani’s talk highlights need for biomarkers to identify patients at risk of developing cachexia - LUNGevity Foundation Mariam Jamal-Hanjani’s talk highlights need for biomarkers to identify patients at risk of developing cachexia - LUNGevity Foundation

Source: LUNGevity Foundation/X

cachexia cancer Lung cancer LUNGevity Foundation Mariam Jamal-Hanjani metastasis OncoDaily Oncology patients TRACERx study